Nebivolol in Patients With Systolic Stage 2 Hypertension
Public ClinicalTrials.gov record NCT01057251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of 5 mg or 20 mg Nebivolol Once Daily on Blood Pressure in Patients With Systolic Stage 2 Hypertension
Study identification
- NCT ID
- NCT01057251
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Forest Laboratories
- Industry
- Enrollment
- 433 participants
Conditions and interventions
Conditions
Interventions
- Nebivolol Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2010
- Primary completion
- Nov 30, 2010
- Completion
- Dec 31, 2010
- Last update posted
- Jan 10, 2012
2010 – 2011
United States locations
- U.S. sites
- 36
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 008 | Foley | Alabama | 36535 | — |
| Forest Investigative Site 021 | Montgomery | Alabama | 36117 | — |
| Forest Investigative Site 006 | Chino | California | 91710 | — |
| Forest Investigative Site 002 | Long Beach | California | 90806 | — |
| Forest Investigative Site 004 | Los Angeles | California | 90057 | — |
| Forest Investigative Site 020 | Temecula | California | 92591 | — |
| Forest Investigative Site 028 | Coral Gables | Florida | 33134 | — |
| Forest Investigative Site 014 | Daytona Beach | Florida | 32114 | — |
| Forest Investigative Site 001 | Fort Lauderdale | Florida | 33308 | — |
| Forest Investigative Site 037 | Fort Lauderdale | Florida | 33316 | — |
| Forest Investigative Site 033 | Hialeah | Florida | 33012 | — |
| Forest Investigative Site 026 | Jacksonville | Florida | 32216 | — |
| Forest Investigative Site 017 | Miami | Florida | 33133 | — |
| Forest Investigative Site 010 | Miami | Florida | 33169 | — |
| Forest Investigative Site 030 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 009 | Atlanta | Georgia | 30338 | — |
| Forest Investigative Site 031 | Augusta | Georgia | 30904 | — |
| Forest Investigative Site 039 | Meridian | Idaho | 83646 | — |
| Forest Investigative Site 007 | Auburn | Maine | 04210 | — |
| Forest Investigative Site 038 | Baltimore | Maryland | 21204 | — |
| Forest Investigative Site 011 | Baltimore | Maryland | 21209 | — |
| Forest Investigative Site 029 | Prince Frederick | Maryland | 20678 | — |
| Forest Investigative Site 023 | Paw Paw | Michigan | 49079 | — |
| Forest Investigative Site 005 | Florissant | Missouri | 63033 | — |
| Forest Investigative Site 041 | Las Vegas | Nevada | 89106 | — |
| Forest Investigative Site 040 | New York | New York | 10010 | — |
| Forest Investigative Site 012 | Hickory | North Carolina | 28601 | — |
| Forest Investigative Site 027 | Salisbury | North Carolina | 28144 | — |
| Forest Investigative Site 024 | Harleysville | Pennsylvania | 19438 | — |
| Forest Investigative Site 013 | Charleston | South Carolina | 29407 | — |
| Forest Investigative Site 035 | Greenville | South Carolina | 29605 | — |
| Forest Investigative Site 018 | Mt. Pleasant | South Carolina | 29464 | — |
| Forest Investigative Site 022 | Simpsonville | South Carolina | 29681 | — |
| Forest Investigative Site 003 | Memphis | Tennessee | 38119 | — |
| Forest Investigative Site 032 | Corpus Christi | Texas | 78404 | — |
| Forest Investigative Site 025 | Richmond | Virginia | 23219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01057251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 10, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01057251 live on ClinicalTrials.gov.